The American Physiological Society Press Release

press release logo

APS Contact: Stacy Brooks

Email: sbrooks@the-aps.org

Phone: 301.634.7209

Twitter: @APSPhysiology

Stem Cell Therapy May Help Recondition Lungs Previously Rejected for Transplant

Bethesda, Md. (May 30, 2014) — Nearly 1,650 people in the U.S. are awaiting lung transplants. Unfortunately, both domestically and abroad, the demand for donor lungs far outpaces the supply. The limited availability of donor lungs can lead to long delays before transplant, leaving patients to face a mortality rate of up to 40 percent while they wait.

Most potentially transplantable lungs are rejected by surgical teams because of injury or dysfunction, such as pulmonary edema (fluid build-up in the lungs). In addition to rendering lungs unusable for transplant, pulmonary edema also signals that the lungs are not functioning properly post-transplant and is a major cause of illness and death among lung transplant recipients. Lungs that can clear fluid better are associated with better outcomes among recipients after transplantation.

In this study, Danny F. McAuley, Gerard F. Curley, Umar I. Hamid, John G. Laffey, Jason Abbott, David H. McKenna, Xiaohui Fang, Michael A. Matthay, and Jae W. Lee looked at whether lungs that were rejected for transplantation because of edema could be “reconditioned” to qualify for transplant. They studied donor lungs that had been rejected for transplantation by the Northern California Transplant Donor Network and that were cleared for research use by the donors’ families.

Roughly 50 percent of these rejected lungs had a decreased capacity to reabsorb lung fluid. The research team found that administering human mesenchymal stem (stromal) cells (MSCs) intravenously restored the ability of the lung to remove alveolar edema fluid more normally. The research highlights the potential for MSC administration as a therapy for resolving pulmonary edema and improving donor lungs before transplantation. The study has implications for increasing the supply of usable donor lungs available for transplant. 

The article “Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation” is published in the American Journal of Physiology—Lung Cellular and Molecular Physiology. It is highlighted as one of this month’s “best of the best” as part of the American Physiological Society’s APSselect program. View the full study here: http://ow.ly/xpxcW. Read all of this month’s selected research articles at http://apsselect.physiology.org/.

NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact Stacy Brooks at sbrooks@the-aps.org or 301-634-7209.

Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents more than 10,500 members and publishes 15 peer-reviewed journals with a worldwide readership.

 


RelatedItems

Inactive Lifestyle Linked to Ozone-Related Lung Disease

Released December 6, 2016 - An inactive lifestyle may increase the risk of environmentally induced asthma symptoms. In a new study published in the American Journal of Physiology—Lung Cellular and Molecular Physiology, U.S. Environmental Protection Agency researchers found that sedentary rats exposed to varying degrees of ozone, a type of air pollution, had higher markers for chronic disease when compared to counterparts that were more active.

High-Fat Diet during Pregnancy Compromises Offspring’s Lung Health

Released March 29, 2017 - Women who follow a high-fat diet during pregnancy may increase their children’s risk for asthma. A mouse study by Oregon Health and Science University researchers suggests that consistent consumption of fat-laden foods may change the immune response of the offsprings’ respiratory system. The article is published in Physiological Reports.

From: 
Email:  
To: 
Email:  
Subject: 
Message:

~/Custom.Templates/PressRelease.aspx